Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001470082 | SCV001674172 | likely benign | not provided | 2023-10-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002368443 | SCV002657417 | likely benign | Inborn genetic diseases | 2022-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003127945 | SCV003802630 | likely benign | Seckel syndrome 1 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003127946 | SCV003802631 | likely benign | Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001470082 | SCV004148489 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | ATR: BP4, BP7 |